A-Alpha Bio vs Octant
A-Alpha Bio
The protein-protein interaction company
50 employees · est. 2017 · Seattle, United States
Octant
Developing synthetic technology and applying next-generation DNA sequencing, gene synthesis, and gene editing to discover safer, more effective, cheaper drugs
69 employees · est. 2017 · Emeryville, United States
Octant is the larger of the two.
Side-by-Side Comparison
| Metric | A-Alpha Bio | Octant |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2017 |
| Headquarters | ||
| Headquarters | Seattle, United States | Emeryville, United States |
| Employees | ||
| Employees | 50 | 69 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Life Sciences |
| Funding Stage | ||
| Funding Stage | Series A | Series B |
| Total Funding | ||
| Total Funding | $60.78M | $119.94M |
| Funding Rounds | ||
| Funding Rounds | 8 | 5 |
| Services | ||
| Services | Quantitative Characterization of Protein Interactions, Machine Learning Model Development for Biology, Platform for Drug Discovery and Optimization | Engineering precision medicines, Clinical research and development, Preclinical studies, Targeting complex cellular mechanisms |
| Target Customers | ||
| Target Customers | Pharmaceutical Companies, Biotechnology Firms, Research Institutions, Healthcare Organizations | Patients with genetic diseases, Individuals with Retinitis Pigmentosa, Cancer patients, Healthcare providers looking for innovative treatments |
| Taxonomy | ||
| Taxonomy | Protein-Protein InteractionsAlphaSeq TechnologyAlphaBind AI PlatformBiotechnology PlatformDrug DiscoveryProtein Engineering +9 | Synthetic TechnologyNext-Generation DNA SequencingGene SynthesisGene EditingSmall Molecule Drug DevelopmentCell Engineering +9 |
| Website | ||
| Website | aalphabio.com | octant.bio |
About A-Alpha Bio
A-Alpha Bio, known as "The protein-protein interaction company," is a pioneering entity in the biotechnology industry focused on the large-scale measurement, prediction, and engineering of protein-protein interactions. Founded in 2017 and based in the United States, this innovative company utilizes...
About Octant
Octant stands at the forefront of the Biotechnology and Life Sciences sectors, leveraging cutting-edge technologies to transform drug discovery. Founded in 2017 and headquartered in the United States, Octant focuses on developing synthetic technology and applying next-generation DNA sequencing, gene...
Also comparing in this category
Comparing more than these two?
Get A-Alpha Bio, Octant and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does A-Alpha Bio compare?
A PDF of A-Alpha Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare A-Alpha Bio with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at A-Alpha Bio on 7 Nov 2026, and Octant on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
